Posted in Industry News, News
London’s life sciences industry received a boost as a US company invested £750,000 into a healthcare accelerator fund, reports the Evening Standard.
The US investment firm, Sandbox Industries, launched Healthbox, to give 10 entrepreneurs £75,000 and links to healthcare professionals, investors, retailers, office space and links to the NHS. The enterprise is backed by Bupa and Serco, which runs blood testing laboratories, with mentors coming from across the healthcare professions.
Looking for a job in the healthcare industry? Start by clicking here, now
Posted in News
Barney Smith at CK Science is looking for a Business Manager to join a manufacturer of chemicals for use in the pharmaceutical, healthcare and medical industries at their site in the North East of the UK.
As a Business Manager you will manage the healthcare section of the company. You will be responsible for:
- Developing market strategy
- Setting sales targets and goals
- Sourcing and managing distributors and suppliers
- Providing high levels of customer service
- Responsible for growing the business and increasing turnover and profitability.
The successful candidate for this Business Manager role must be qualified to degree level in a scientific based subject or possess equivalent experience and a proven track record in sales and manufacturing, ideally within pharmaceuticals, medical devices or cleanroom supplies.
How to apply:
For more information or to apply for this Business Manager role please contact Barney Smith on 0191 384 8905 or email email@example.com. Please quote reference DH24239 in all correspondence.
Posted in General, News
Our client, based in the East Midlands, is a leading healthcare, skincare, cosmetics and beauty products manufacturer and is seeking a Technician to work in their Sun/Skin care area.
This Technician role will involve supporting the design and production of sun and skin care technology to meet the agreed NPD project briefs and deadlines.
The ideal candidate for this Technician position will have experience in the cosmetics, skincare or suncare manufacturing industry or be from a similar production/manufacturing environment and be immediately available to start work. It is preferable that you have a degree or equivalent in a relevant scientific subject.
For more information or to apply for this Technician role, please contact Russell Oakley at CK Science on 0114 283 9956 or email firstname.lastname@example.org. Please quote reference SH20314 in all correspondence.
Posted in General, News
CK Science, the UK’s largest independent specialist scientific and technical recruitment consultancy, is proud to announce our corporate partnership with Biocity.
Based in Nottingham, Biocity is one of Europe’s largest bioscience incubators. The award winning site currently hosts nearly 70 companies and over 525 employees and aims to provide a home for developing biotechnology and healthcare companies.
By entering into partnership with Biocity, CK Science are able to support new start-up companies and facilitate the provision of high quality scientific recruitment advice and services to existing bioscience companies in the East Midlands.
Speaking of the partnership, Liam O’Connell, Director at CK Science stated, “CK Science are proud to announce our partnership with Biocity. We are passionate about supporting biotechnology and healthcare companies in their early stages of development. As a company we are very much looking forward to granting businesses at Biocity access to our expertise in recruiting high calibre staff to the scientific industry.”
As corporate partners, CK Science will be regular visitors to the Biocity site and is very much looking forward to attending regular advisory clinics and business networking events.
Posted in General, News
In recent years, pharmaceutical companies have come under increasing pressure to change their approach to providing cheap drugs to people in the developing world. Many have faced fierce criticism for their failure to drop prices for HIV drugs while millions died in Africa and Asia, for defending patents. However, it seems the Chief Executive of GSK, Andrew Witty has a plan to fix this problem.
As reported in the Daily Telegraph, GSK is planning to share scientific data and laboratories in a bid to wipe out tropical diseases, such as malaria. Andrew Witty, the Chief Executive of GSK who recently spent time in some of the world’s poorest continents, including Africa, said the global pharmaceutical company has a “genuine appetite to change the landscape of healthcare for the world’s poorest people”. In fact, it is estimated that Africa carries 70% of the world’s healthcare burden, but only receives 3% of healthcare resources.
In 2009, GSK announced it would create a patent pool for some of its existing products and not-for-profit-pricing on a variety of drugs for the developing world. In addition, the pharmaceutical giant plans to release 13,500 of its compounds that are believed to have the potential to be developed into new malaria treatments.
GSK will also operate an ‘Open Lab’ scheme whereby the company will open one of its laboratories in Tres Santocs, Spain, for non-GSK scientists to use to investigate treatments for other tropical diseases. The lab will accommodate 60 scientists who will benefit from £4.9m of funding from GSK to help with their research. Speaking of this innovative ‘Open Lab’ scheme, Witty stated, Speaking before leaving for New York, Mr. Witty said: “Malaria is a dreadful disease which stalks the fields and villages of many parts of the least developed world. It has been an intractable problem for decades. Enormous progress has been made through bed net programmes, for example, but a really effective treatment has been somewhat elusive. We need to enlist the help of scientists around the world and to make it as easy as possible for that brilliant scientist, wherever they are, to find that initial spark that could be the breakthrough.”